Announcements Trials
Browse Landscape

Phase

Phase 2 176Phase 3 75Phase 1 68Phase 1/2 42Phase 4 8Phase NA 4Phase EARLY_PHASE1 2Phase 2/3 2

Status

Unknown 2Recruiting 2

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

HR Positive HER2 Negative Advanced Breast Cancer 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Breast Carcinoma In Situ 1Advanced HR - Positive, HER2 - Negative Breast Cancer 1Advanced Breast Cancer 1

Interventions

Exercise 126Surveys and Questionnaires 59Standard of Care 58Early Intervention, Educational 55Methods 54Educational Status 53Magnetic Resonance Spectroscopy 50Acupuncture Therapy 48Blood Specimen Collection 46Radiotherapy 39Mammography 39Control Groups 35Counseling 32Therapeutics 30Practice Guidelines as Topic 30Cyclophosphamide 29Biopsy 28Sentinel Lymph Node Biopsy 27Psychiatric Rehabilitation 27Yoga 23Neoadjuvant Therapy 23Mastectomy, Segmental 23Resistance Training 22Interviews as Topic 21Surgical Procedures, Operative 19Palliative Care 19High-Energy Shock Waves 19Trastuzumab 18Doxorubicin 18Cognitive Behavioral Therapy 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Fulvestrant × Breast × Clear all
NCT06856200 2025-03-04

A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

Fudan University

Phase NA Recruiting
36 enrolled
Breast

Advanced HR - Positive, HER2 - Negative Breast Cancer

NCT05890287 2023-06-06

A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy

Tianjin Medical University Cancer Institute and Hospital

Phase NA Recruiting
60 enrolled
Breast

HR Positive HER2 Negative Advanced Breast Cancer

NCT05047848 2021-09-17

Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer

Liaoning Cancer Hospital & Institute

Phase NA Unknown
82 enrolled
Breast

Advanced Breast Cancer

NCT00126464 2013-11-06

Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast

National Cancer Institute (NCI)

Phase NA Unknown
100 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡